Literature DB >> 29071717

SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.

S-L Xie1,2, S Fan1,2, S-Y Zhang1, W-X Chen1,2, Q-X Li1,2, G-K Pan1,2, H-Q Zhang1,2, W-W Wang3, B Weng4, Z Zhang5, J-S Li1,2, Z-Y Lin1,2.   

Abstract

A sub-population of chemoresistant cells exhibits biological properties similar to cancer stem cells (CSCs), and these cells are believed to be a main cause for tumor relapse and metastasis. In our study, we explored the role of SOX8 and its molecular mechanism in the regulation of the stemness properties and the epithelial mesenchymal transition (EMT) of cisplatin-resistant tongue squamous cell carcinoma (TSCC) cells. We found that SOX8 was upregulated in cisplatin-resistant TSCC cells, which displayed CSC-like properties and exhibited EMT. SOX8 was also overexpressed in chemoresistant patients with TSCC and was associated with higher lymph node metastasis, advanced tumor stage and shorter overall survival. Stable knockdown of SOX8 in cisplatin-resistant TSCC cells inhibited chemoresistance, tumorsphere formation, and EMT. The Wnt/β-catenin pathway mediated the cancer stem-like properties in cisplatin-resistant TSCC cells. Further studies showed that the transfection of active β-catenin in SOX8 stable-knockdown cells partly rescued the SOX8 silencing-induced repression of stem-like features and chemoresistance. Through chromatin immunoprecipitation and luciferase assays, we observed that SOX8 bound to the promoter region of Frizzled-7 (FZD7) and induced the FZD7-mediated activation of the Wnt/β-catenin pathway. In summary, SOX8 confers chemoresistance and stemness properties and mediates EMT processes in chemoresistant TSCC via the FZD7-mediated Wnt/β-catenin pathway.
© 2017 UICC.

Entities:  

Keywords:  Cancer stem cell; EMT; SOX transcription factors; Wnt/β-catenin pathway; cisplatin resistance; tongue squamous cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 29071717     DOI: 10.1002/ijc.31134

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  39 in total

1.  Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.

Authors:  Xian Lin; Ai-Min Li; Yong-Hao Li; Rong-Cheng Luo; Zhen Liu; Yu-Jiao Zou; Yi-Yi Liu; Chen Liu; Ying-Ying Xie; Shi Zuo; Zhan Liu; Wei-Yi Fang
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

2.  Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.

Authors:  Sirorut Sinnung; Tavan Janvilisri; Pichamon Kiatwuthinon
Journal:  Mol Cell Biochem       Date:  2021-01-09       Impact factor: 3.396

3.  Variability of Betweenness Centrality and Its Effect on Identifying Essential Genes.

Authors:  Christina Durón; Yuan Pan; David H Gutmann; Johanna Hardin; Ami Radunskaya
Journal:  Bull Math Biol       Date:  2018-10-22       Impact factor: 1.758

4.  The oncogenic role of SOX8 in endometrial carcinoma.

Authors:  Wenyan Tian; Zhanghuan Li; Lu Bai; Lingli Chen; Ye Yan; Huihui Li; Yanyan Han; Fei Teng; Chao Gao; Fengxia Xue; Yingmei Wang
Journal:  Cancer Biol Ther       Date:  2020-11-16       Impact factor: 4.742

5.  Differential expression of members of SOX family of transcription factors in failing human hearts.

Authors:  Chia-Feng Liu; Ying Ni; Varun Thachil; Michael Morley; Christine S Moravec; Wai Hong Wilson Tang
Journal:  Transl Res       Date:  2021-10-22       Impact factor: 7.012

6.  Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma.

Authors:  Xinmiao Wang; Rui Li; Luping Wu; Yang Chen; Shaopeng Liu; Hui Zhao; Yifan Wang; Lin Wang; Zhe Shao
Journal:  Cell Biosci       Date:  2022-04-27       Impact factor: 7.133

7.  SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.

Authors:  Xianglin Hao; Fei Han; Bangjin Ma; Ning Zhang; Hongqiang Chen; Xiao Jiang; Li Yin; Wenbin Liu; Lin Ao; Jia Cao; Jinyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2018-05-31

Review 8.  Frizzled Receptors as Potential Therapeutic Targets in Human Cancers.

Authors:  Chui-Mian Zeng; Zhe Chen; Li Fu
Journal:  Int J Mol Sci       Date:  2018-05-22       Impact factor: 5.923

9.  Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification.

Authors:  Charlie Gourley; C Simon Herrington; Robert L Hollis; Barbara Stanley; John P Thomson; Michael Churchman; Ian Croy; Tzyvia Rye; Clare Bartos; Fiona Nussey; Melanie Mackean; Alison M Meynert; Colin A Semple
Journal:  NPJ Precis Oncol       Date:  2021-06-02

10.  The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma.

Authors:  Chi T Viet; Gary Yu; Kesava Asam; Carissa M Thomas; Angela J Yoon; Yan Chen Wongworawat; Mina Haghighiabyaneh; Courtney A Kilkuts; Caitlyn M McGue; Marcus A Couey; Nicholas F Callahan; Coleen Doan; Paul C Walker; Khanh Nguyen; Stephanie C Kidd; Steve C Lee; Anupama Grandhi; Allen C Cheng; Ashish A Patel; Elizabeth Philipone; Olivia L Ricks; Clint T Allen; Bradley E Aouizerat
Journal:  Biomark Res       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.